Update and interpretation of the European LeukemiaNet guideline for the diagnosis and treatment of acute myeloid leukemia in 2022 / 白血病·淋巴瘤

The 2010 and 2017 editions of the European LeukemiaNet (ELN) guideline for the diagnosis and treatment of acute myeloid leukemia (AML) have been widely used in clinical practice. With further understanding of the molecular biological mechanisms of AML and tremendous progress in the application of clinically targeted drugs, the 2022 edition ELN AML guidelines were recently published online in the Blood. The article interprets the updated key points of the guideline.